Population pharmacokinetic modeling of missed mycophenolate mofetil doses: Impact on exposure and exploration of mitigation strategies
PLOS One · 2025
DOI: 10.1371/journal.pone.0330854 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Franck Maizaud und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France. Hauptthemen laut MEDLINE: Mycophenolic Acid, Immunosuppressive Agents, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Missed doses of mycophenolate mofetil (MMF) are frequent in transplant recipients and may lead to subtherapeutic exposure to mycophenolic acid (MPA), potentially compromising graft function. However, current guidance on how to manage such deviations remains empirical and is not supported by pharmacokinetic evidence.
Methods
We used two validated population pharmacokinetic models of MPA to simulate steady-state exposure in virtual cohorts of renal transplant recipients treated with MMF. Scenarios included full missed doses, delays in intake (2–10 hours), and compensation strategies (50% or 100% added at the next dose). Simulations were performed for six dose regimens (500–1250 mg BID) and analyzed in terms of AUC 0–12h , proportion of patients outside the target range (30–60 mg·h/L), and time to return to steady state.
Results
A fully missed dose resulted in a 40–60% reduction in AUC 0–12h , with delayed return to steady state (up to 72 hours). Delays ≤6 hours caused minimal impact (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.
- INSERM UMR-1248 "Pharmacology & Transplantation", Limoges, France.
- Fédération Hospitalo-Universitaire "Survival Optimization in Organ Transplantation" (FHU SUPORT), Limoges, France.
ORCID-Profile: Franck Maizaud, Yeleen Fromage, Jean-Baptiste Woillard, Caroline Monchaud
Zitieren
APA
Maizaud, F., Arraki-Zava, S., Sayadi, H., Fromage, Y., Marquet, P., Woillard, J. B., & Monchaud, C. (2025). Population pharmacokinetic modeling of missed mycophenolate mofetil doses: Impact on exposure and exploration of mitigation strategies. PLOS One. https://doi.org/10.1371/journal.pone.0330854
Vancouver
Maizaud F, Arraki-Zava S, Sayadi H, Fromage Y, Marquet P, Woillard JB, et al. Population pharmacokinetic modeling of missed mycophenolate mofetil doses: Impact on exposure and exploration of mitigation strategies. PLOS One. 2025. doi:10.1371/journal.pone.0330854
BibTeX
@article{Maizaud2025,
author = {Maizaud, Franck and Arraki-Zava, Selim and Sayadi, Hamza and Fromage, Yeleen and Marquet, Pierre and Woillard, Jean-Baptiste and Monchaud, Caroline},
title = {Population pharmacokinetic modeling of missed mycophenolate mofetil doses: Impact on exposure and exploration of mitigation strategies},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0330854}
}
EUVIMED